Avid Bioservices Inc (CDMO)

[freethemice]

FF, both the Abraxane study and the FOLFIRINOX study were done with only metastatic patients,
just as the Peregrine trial was done. FOLFIRINOX is a combination of 4 chemo drugs, and
Abraxane is albumin-bound paclitaxel. So the big difference was adding a monoclonal
antibody to gemcitabine, instead of more chemo drugs. I agree with your assessment that the
patients were dying faster than bavi could work. It will be interesting to see if
there was a subset that did better.